BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Valeant Pharmaceuticals International (VRX) Has Approached MEDA About a Takeover; MEDA Chairman Denies Claim


7/27/2011 7:16:28 AM

Valeant Pharmaceuticals International Inc. (VRX), the drugmaker that has pursued more than 10 acquisitions in the past year, approached Sweden’s Meda AB (MEDAA) about a takeover, said two people with knowledge of the matter. The approach was informal and may not lead to a deal, said one of the people, who declined to be identified because the situation is private. Meda, based in Solna, Sweden, had a market value of about 21.5 billion kronor ($3.4 billion) based on its last closing stock price. The companies have a history of doing deals together. Valeant, based in Mississauga, Ontario, said in June it would buy rights to sell two of Meda’s medicines in the U.S. and Canada. Three years ago, Valeant sold its European drug business to Meda, giving the Swedish company access to the faster-growing eastern European and Russian markets. The Wall Street Journal reported the approach yesterday.


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES